We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
28 hedge funds and large institutions have $32.9M invested in Interpace Biosciences, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
8% more funds holding
Funds holding: 26 → 28 (+2)
5% less capital invested
Capital invested by funds: $34.7M → $32.9M (-$1.82M)
Holders
28
Holders Change
+2
Holders Change %
+7.69%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
9
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$65.1K |
| 2 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$60.9K |
| 3 |
Renaissance Technologies
New York
|
+$24K |
| 4 |
MA
Minerva Advisors
Bala Cynwyd,
Pennsylvania
|
+$15.2K |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$7.84K |
